These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 29552730)

  • 1. Impact of cumulative exposure to high-dose oral glucocorticoids on fracture risk in Denmark: a population-based case-control study.
    Amiche MA; Abtahi S; Driessen JHM; Vestergaard P; de Vries F; Cadarette SM; Burden AM
    Arch Osteoporos; 2018 Mar; 13(1):30. PubMed ID: 29552730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticosteroid use and risk of hip fracture: a population-based case-control study in Denmark.
    Vestergaard P; Olsen ML; Paaske Johnsen S; Rejnmark L; Sørensen HT; Mosekilde L
    J Intern Med; 2003 Nov; 254(5):486-93. PubMed ID: 14535971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of systemic glucocorticoids and the risk of major osteoporotic fractures in patients with sarcoidosis.
    Oshagbemi OA; Driessen JHM; Pieffers A; Wouters EFM; Geusens P; Vestergaard P; van den Bergh J; Franssen FME; de Vries F
    Osteoporos Int; 2017 Oct; 28(10):2859-2866. PubMed ID: 28638981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of high-dose intermittent systemic glucocorticoids and the risk of fracture in patients with chronic obstructive pulmonary disease.
    Oshagbemi OA; Burden AM; Shudofsky KN; Driessen JHM; Vestergaard P; Krings A; Franssen FME; van den Bergh J; de Vries F
    Bone; 2018 May; 110():238-243. PubMed ID: 29462672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fracture risk with intermittent high-dose oral glucocorticoid therapy.
    De Vries F; Bracke M; Leufkens HG; Lammers JW; Cooper C; Van Staa TP
    Arthritis Rheum; 2007 Jan; 56(1):208-14. PubMed ID: 17195223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Systemic Glucocorticoid Use on Fracture Risk: A Population-Based Study.
    Koh JW; Kim J; Cho H; Ha YC; Kim TY; Lee YK; Kim HY; Jang S
    Endocrinol Metab (Seoul); 2020 Sep; 35(3):562-570. PubMed ID: 32981298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fracture risk in oral glucocorticoid users: a Bayesian meta-regression leveraging control arms of osteoporosis clinical trials.
    Amiche MA; Albaum JM; Tadrous M; Pechlivanoglou P; Lévesque LE; Adachi JD; Cadarette SM
    Osteoporos Int; 2016 May; 27(5):1709-18. PubMed ID: 26694595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risk of fracture in incident multiple sclerosis patients: the Danish National Health Registers.
    Bazelier MT; Bentzen J; Vestergaard P; Stenager E; Leufkens HG; van Staa TP; de Vries F
    Mult Scler; 2012 Nov; 18(11):1609-16. PubMed ID: 22472998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucocorticoids Are Associated with an Increased Risk for Vertebral Fracture in Patients with Rheumatoid Arthritis.
    Kim D; Cho SK; Park B; Jang EJ; Bae SC; Sung YK
    J Rheumatol; 2018 May; 45(5):612-620. PubMed ID: 29545455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Glucocorticoids and Risk of Community-Acquired Staphylococcus aureus Bacteremia: A Population-Based Case-Control Study.
    Smit J; Kaasch AJ; Søgaard M; Thomsen RW; Nielsen H; Frøslev T; Schønheyder HC
    Mayo Clin Proc; 2016 Jul; 91(7):873-80. PubMed ID: 27289410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy.
    Van Staa TP; Laan RF; Barton IP; Cohen S; Reid DM; Cooper C
    Arthritis Rheum; 2003 Nov; 48(11):3224-9. PubMed ID: 14613287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statin but not non-statin lipid-lowering drugs decrease fracture risk: a nation-wide case-control study.
    Rejnmark L; Vestergaard P; Mosekilde L
    Calcif Tissue Int; 2006 Jul; 79(1):27-36. PubMed ID: 16868664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of dipeptidyl peptidase 4 inhibitors and fracture risk compared to use of other anti-hyperglycemic drugs.
    Driessen JH; van Onzenoort HA; Starup-Linde J; Henry R; Neef C; van den Bergh J; Vestergaard P; de Vries F; Burden AM
    Pharmacoepidemiol Drug Saf; 2015 Oct; 24(10):1017-25. PubMed ID: 26183226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Average daily glucocorticoid dose, number of prescription days, and cumulative dose in the initial 90 days of glucocorticoid therapy are associated with subsequent hip and clinical vertebral fracture risk: a retrospective cohort study using a nationwide health insurance claims database in Japan.
    Iki M; Fujimori K; Nakatoh S; Tamaki J; Ishii S; Okimoto N; Imano H; Ogawa S
    Osteoporos Int; 2024 May; 35(5):805-818. PubMed ID: 38267664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of glucocorticoids and risk of venous thromboembolism: a nationwide population-based case-control study.
    Johannesdottir SA; Horváth-Puhó E; Dekkers OM; Cannegieter SC; Jørgensen JO; Ehrenstein V; Vandenbroucke JP; Pedersen L; Sørensen HT
    JAMA Intern Med; 2013 May; 173(9):743-52. PubMed ID: 23546607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of vertebral and non-vertebral fractures in patients with sarcoidosis: a population-based cohort.
    Bours S; de Vries F; van den Bergh JPW; Lalmohamed A; van Staa TP; Leufkens HGM; Geusens PPP; Drent M; Harvey NC
    Osteoporos Int; 2016 Apr; 27(4):1603-1610. PubMed ID: 26630976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose oral glucocorticoid therapy and risk of osteoporotic fractures in patients with rheumatoid arthritis: a cohort study using the Clinical Practice Research Datalink.
    Abtahi S; Driessen JHM; Burden AM; Souverein PC; van den Bergh JP; van Staa TP; Boonen A; de Vries F
    Rheumatology (Oxford); 2022 Apr; 61(4):1448-1458. PubMed ID: 34255815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fracture risk in users of oral anticoagulants: a nationwide case-control study.
    Rejnmark L; Vestergaard P; Mosekilde L
    Int J Cardiol; 2007 Jun; 118(3):338-44. PubMed ID: 17055083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton pump inhibitor use and the risk of osteoporosis and fracture in stroke patients: a population-based cohort study.
    Lin SM; Yang SH; Liang CC; Huang HK
    Osteoporos Int; 2018 Jan; 29(1):153-162. PubMed ID: 29032384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fracture risk associated with systemic and topical corticosteroids.
    Vestergaard P; Rejnmark L; Mosekilde L
    J Intern Med; 2005 Apr; 257(4):374-84. PubMed ID: 15788008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.